FDA DEVICE FACTS
SureFlex HD Steerable Sheath, VersaCross HD Steerable Sheath
Baylis Medical Company, Inc.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Similar The indications for use of the subject device is similar to that of the predicate device, with a difference in reference to the compatible mapping systems. The subject device’s compatibility and ability to be visualized on impedance -based EAM systems encompasses the predicate device’s compatible mapping system (CARTO navigation systems). Appropriate validation testing has been completed to demonstrate the su bject device meets its user requirements, ensures compatibility with accessory / ancillary devices (for use with any impedance-based EAM systems), and achieves its intended use. D ifferences in indications for use do not raise new or different questions of safety or effectiveness. Fundamental Scientific Technology Identical Both subject and predicate device rely on user controlled mechanical manipulation to percutaneously gain access to vasculature and chambers of the heart, with shaft visualization when used with a compatible mapping system. Operating Principles Identical The principles of operation for both subject and predicate device rely on t he user to direct the device assembly to the desired site to facilitate introduction of cardiovascular catheters to the heart. Mechanism of Action Identical The mechanism of action for both subject and predicate device include a steerable sheath with manual actuation to provide steerability and to track to target anatomy, while using an impedance -based electroanatomical mapping system to support sheath visualization. SureFlex HD Steerable Sheath, VersaCross HD Steerable Sheath Baylis Medical Company Inc. Traditional 510(k) - K231227 012-
Characteristic Comparison Results Comments Environment Identical Both subject and predicate device are used in a sterile environment where facilities are appropriately equipped and staffed to perform transseptal procedures. Materials Similar Appropriate biocompatibility verification testing has been conducted for the subject device and results demonstrate the device meets biological safety requirements as per ISO 10993-1 and FDA guidance. Differences in material between the subject and predicate devices do no raise new or different questions of safety or effectiveness.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。